Search results
Navigating Market Uncertainty: Intrinsic Value of UnitedHealth Group Inc
GuruFocus.com via Yahoo Finance· 12 hours agoIn this article, we will take a look into UnitedHealth Group Inc's (NYSE:UNH) DCF analysis, a...
2 Revolutionary Growth Stocks to Buy in the 2024 Bull Market
The Motley Fool via AOL· 11 hours agoIf you're looking for revolutionary businesses to add to your portfolio, here are two no-brainer stocks you may want to scoop up in the near future. 1. UnitedHealth
Medicare Advantage unrest, Change Healthcare fallout and more big takeaways from insurers’ Q1
Healthcare Dive via Yahoo Finance· 16 hours agoAll major payers saw elevated utilization but only an unprepared few struggled with the trend, the...
Decoding UnitedHealth Group Inc (UNH): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoUnitedHealth Group Inc (NYSE:UNH) faces a net loss in Q1 2024 amidst a cyberattack and sale of its...
Smart Money Is Betting Big In UNH Options - UnitedHealth Group (NYSE:UNH)
Benzinga· 4 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on UnitedHealth Group. Our analysis of options history for UnitedHealth ...
The unprecedented health-care hack that may affect you
Washington Post· 2 days agoUnitedHealth Group is both the nation’s largest insurer and its largest employer of physicians. It owns pharmacies and home health agencies. One of its ...
Change Healthcare lacked safeguards even as it gave security advice - Roll Call
CQ Politics· 7 days agoIn the months surrounding UnitedHealth Group Inc.’s $13 billion purchase of software company Change...
10 things to know about Optum's bank
Becker’s Hospital Review· 6 days agoUnitedHealth Group's Optum has its own bank, but it has no branches and is dedicated solely to healthcare services. 1. Launched in 2003 in Salt Lake City ...
Top hedge fund stocks: Here are their most popular picks
Bankrate via AOL· 3 days agoThe largest stocks offer significant...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 4 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
